Methylxanthines and Phosphodiesterase Inhibitors in the Treatment of Airways Disease
Seiten
1994
Taylor & Francis Ltd (Verlag)
978-1-85070-597-0 (ISBN)
Taylor & Francis Ltd (Verlag)
978-1-85070-597-0 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Defines current thinking on the anti-inflammatory and muscle-relaxing properties of this group of agents for patients with allergic airways disease. These latest phamacological, mechanistic and clinical studies provide an up-to-date overview of today's research in allergic respiratory medicine.
This is a technically detailed state-of-the-art text on phosphodiesterase inhibition and the practical applications of theophylline and other phosphodiesterase inhibitors in asthma and chronic obstructive airways disease. It contains important new information on the mechanisms of drug action and on the inhibition of individual isoenzymes of the phosphodiesterase enzyme family as a potentially useful, safe, and non-toxic approach to asthma therapy.
This is a technically detailed state-of-the-art text on phosphodiesterase inhibition and the practical applications of theophylline and other phosphodiesterase inhibitors in asthma and chronic obstructive airways disease. It contains important new information on the mechanisms of drug action and on the inhibition of individual isoenzymes of the phosphodiesterase enzyme family as a potentially useful, safe, and non-toxic approach to asthma therapy.
Xanthines and xanthine-like drugs for asthma. Current status of cyclic nucleotide phosphodiesterase isoenzymes. The human cycle nucleotide phosphodiesterases. Phosphodiesterase inhibitors and airways muscle. Cyclic AMP phosphodiesterase inhibition, theophylline, and pharmacological inhibition of neutrophil and eosinophil function. The anti-inflammatory actions of theophylline and selective phosphodiesterase inhibitors: relevance to the therapy of allergic airways disease. The anti-inflammatory actions of theophylline. Methylxanthines in the treatment of cystic fibrosis. Clinical efficacy o theophylline in chronic obstructive pulmonary disease. Future prospects for cyclic nucleotide phosphodiesterase isoenzyme inhibitors in asthma. Index.
| Erscheint lt. Verlag | 15.10.1994 |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Gewicht | 508 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Medizinische Fachgebiete ► Innere Medizin ► Pneumologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| ISBN-10 | 1-85070-597-6 / 1850705976 |
| ISBN-13 | 978-1-85070-597-0 / 9781850705970 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Aus der Praxis für die Praxis
Buch (2022)
Thieme (Verlag)
CHF 99,40
International Trauma Life Support (ITLS)
Buch | Softcover (2024)
Hogrefe AG (Verlag)
CHF 91,00
